Gts Securities LLC Amgen Inc Call Options Transaction History

Gts Securities LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$262.75 - $319.31 $2.21 Million - $2.68 Million	-8,400 Reduced 8.23%	93,700 $29.3 Million
Q1 2024 May 15, 2024	SELL	$268.87 - $324.56 $4.65 Million - $5.61 Million	-17,300 Reduced 14.49%	102,100 $29 Million
Q4 2023 Feb 14, 2024	SELL	$255.7 - $288.46 $8.82 Million - $9.95 Million	-34,500 Reduced 22.42%	119,400 $34.4 Million
Q3 2023 Nov 15, 2023	BUY	$218.65 - $271.46 $33.7 Million - $41.8 Million	153,900 New	153,900 $41.4 Million

3,054

409M

7.19M

6.26M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $173B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Gts Securities LLC with notifications on news.